[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-537209-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-537209-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","school-nurse-bootcamp-reporting-use-of-undesignated-medications","School Nurse Bootcamp - Reporting Use of Undesignated Medications","","School Nurse Bootcamp material presented by ISBE’s Wellness Team explains newly launched reporting requirements for undesignated medications administered in schools. It covers the purpose of reporting use of medications such as epinephrine, asthma medication, and opioid antagonist, and provides an overview of Illinois laws including 105 ILCS 5/22-30. The session breaks down school code provisions on self-administration and self-carry, administration pathways, and asthma episode emergency response protocols.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/school-nurse-bootcamp-reporting-use-of-undesignated-medications/537209/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/school-nurse-bootcamp-reporting-use-of-undesignated-medications/537209.png","ImageObject",300,407,{"name":42,"@type":43},"Muffet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-10-10",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What reporting requirements does this presentation introduce for undesignated medications?","Question",{"text":63,"@type":64},"It introduces newly launched means to report to ISBE when an undesignated medication has been administered, including epinephrine, asthma medication, or opioid antagonist.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which law section is referenced for undesignated medications in school settings?",{"text":68,"@type":64},"The presentation cites (105 ILCS 5/22-30) as the Illinois School Code provision addressing self-administration and related permissions.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the School Code permit regarding self-administration and self-carry?",{"text":72,"@type":64},"It addresses self-administration and self-carry of asthma medication and epinephrine injectors for students, and also permits districts to maintain undesignated epinephrine, opioid antagonist, and undesignated asthma medication.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},537209,1791688760,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},962090768927,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","School Nurse Bootcamp: Reporting use of Undesignated  \nMedications  \nPresented by ISBE's Wellness Team August 16, 2022  \nEquity ● Quality ● Collaboration ● Community  \n1  \nPresenter:  \nRebecca Doran  \nSchool Nurse Principal Consultant Illinois State Board of Education  \nEquity ● Quality ● Collaboration ● Community  \n2  \nQuestions  \n• Questions are welcome during the live presentation, enter them into the question box  \n• A compiled FAQ document, Power Point, and webinar recording will be made available  \n3  \nISBE Vision & Mission  \nVision:  \nEach and every child is equipped to make meaningful contributions to society and live life to its fullest potential.  \nMission:  \nProvide each and every child with safe and healthy learning conditions, great educators, and equitable opportunities by practicing data-informed stewardship of resources and policy development, all done in partnership with educators, families, and stakeholders.  \n4  \nISBE Goals  \n5  \nPurpose  \n• This presentation will introduce the newly launched means to report to ISBE when an undesignated medication has been administered whether it is epinephrine, asthma medication, or opioid antagonist.  \n• Will provide an overview of laws related to  \nhaving undesignated medications available at your school.  \nEquity ● Quality ● Collaboration ● Community  \n6  \nIllinois School Code permits undesignated medications (3)  \nThis section of school code addresses selfadministration and self-carry of asthma medication and epinephrine injectors for students.  \nAdditionally, permits school districts to maintain undesignated epinephrine, opioid antagonist, and undesignated asthma medication.  \n(105 ILCS 5/22-30)  \n7  \nBreaking down what is in School Code  \n• Self-administration and self-carry of asthma  \n.  \nmedication and epinephrine injectors  \n• Administration of epinephrine injectors.  \n• Administration of undesignated epinephrine injectors.  \n• Administration of opioid antagonist.  \n• Administration of undesignated asthma medication.  \n• Asthma episode emergency response protocol  \n8  \nWhat that means  \n\n|  |  |  |\n| --- | --- | --- |\n|  | \u003Cbr>Selfadministration |  |\n|  |  |  |\n\n\n|  |  |  |\n| --- | --- | --- |\n|  |   Self-carry   |  |\n|  |  |  |\n\nAsthma medication  \nEpinephrine  \nStudent specific epinephrine may self-carry and self-administer.  \nStudent specific asthma medication may self-carry and self-administer.  \n9  \nBreaking down what is in School Code  \n• Self-administration and self-carry of asthma medication and epinephrine injectors.  \n• Administration of epinephrine injectors.  \n• Administration of undesignated epinephrine injectors.  \n• Administration of opioid antagonist.  \n• Administration of undesignated asthma medication.  \n• Asthma episode emergency response protocol  \n10","cbCaij1TMNt4kMJs","https://ap.wps.com/l/cbCaij1TMNt4kMJs","pdf",1431396,58,"English","# Purpose\n## Reporting use of undesignated medications\n## Overview of related laws\n# Illinois School Code permissions\n## Self-administration and self-carry provisions\n## Allowed medication categories\n# Breaking down School Code\n## Administration types and emergency response\n# What that means\n## Student self-carry and self-administration","[{\"question\":\"What reporting requirements does this presentation introduce for undesignated medications?\",\"answer\":\"It introduces newly launched means to report to ISBE when an undesignated medication has been administered, including epinephrine, asthma medication, or opioid antagonist.\"},{\"question\":\"Which law section is referenced for undesignated medications in school settings?\",\"answer\":\"The presentation cites (105 ILCS 5/22-30) as the Illinois School Code provision addressing self-administration and related permissions.\"},{\"question\":\"What does the School Code permit regarding self-administration and self-carry?\",\"answer\":\"It addresses self-administration and self-carry of asthma medication and epinephrine injectors for students, and also permits districts to maintain undesignated epinephrine, opioid antagonist, and undesignated asthma medication.\"}]","School Nurse Bootcamp - Reporting Use of Undesignated Medications | PDF",1791604204,146]